Cargando…
Alteration of Epigenetic Modifiers in Pancreatic Cancer and Its Clinical Implication
The incidence of pancreatic cancer has considerably increased in the past decade. Pancreatic cancer has the worst prognosis among the cancers of the digestive tract because the pancreas is located in the posterior abdominal cavity, and most patients do not show clinical symptoms for early detection....
Autores principales: | Hung, Yu-Hsuan, Hsu, Ming-Chuan, Chen, Li-Tzong, Hung, Wen-Chun, Pan, Mei-Ren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617267/ https://www.ncbi.nlm.nih.gov/pubmed/31238554 http://dx.doi.org/10.3390/jcm8060903 |
Ejemplares similares
-
Orchestration of H3K27 methylation: mechanisms and therapeutic implication
por: Pan, Mei-Ren, et al.
Publicado: (2017) -
From Friend to Enemy: Dissecting the Functional Alteration of Immunoregulatory Components during Pancreatic Tumorigenesis
por: Wang, Hui-Ching, et al.
Publicado: (2018) -
The Trinity: Interplay among Cancer Cells, Fibroblasts, and Immune Cells in Pancreatic Cancer and Implication of CD8(+) T Cell-Orientated Therapy
por: Hung, Yu-Hsuan, et al.
Publicado: (2022) -
The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer
por: Pan, Mei-Ren, et al.
Publicado: (2016) -
G9a orchestrates PCL3 and KDM7A to promote histone H3K27 methylation
por: Pan, Mei-Ren, et al.
Publicado: (2015)